AU2001268349A1 - Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling - Google Patents
Apparatus and method for mask free delivery of an inspired gas mixture and gas samplingInfo
- Publication number
- AU2001268349A1 AU2001268349A1 AU2001268349A AU2001268349A AU2001268349A1 AU 2001268349 A1 AU2001268349 A1 AU 2001268349A1 AU 2001268349 A AU2001268349 A AU 2001268349A AU 2001268349 A AU2001268349 A AU 2001268349A AU 2001268349 A1 AU2001268349 A1 AU 2001268349A1
- Authority
- AU
- Australia
- Prior art keywords
- gas
- person
- sampling
- breath
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
APPARATUS AND METHOD FOR MASK FREE DELIVERY OF AN INSPIRED GAS MLXTURE
AND
GAS SAMPLING
CROSS-REFERENCE TO RELATED APPLICATION
This application is a continuation-in-part of U.S. patent
application Serial No. 09/592,943 filed June 13, 2000, the contents
of which are incorporated herein.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to an apparatus and method for the
delivery of an inspired gas (e.g., supplemental oxygen (O2) gas) to a
person combined with sampling of the gas exhaled by the person, such sampling for use, for example, in monitoring the ventilation of
the person or for inferring the concentration of a drug or gas in the
person's blood stream. More particularly, the invention relates to
an apparatus and method where such delivery of the inspired gas
and gas sampling are accomplished without the use of a sealed face mask.
2. Description of Related Art
In various medical procedures and treatments performed on patients, there is a need to deliver a desired inspired gas composition, e.g., supplemental oxygen, to the patient. In
procedures involving the delivery of anesthesia or where a patient is
otherwise unconscious and ventilated, the delivery of oxygen and gaseous or vaporized or nebulized drugs is typically accomplished
via a mask that fits over the patient's nose and mouth and is sealed
thereto or by a tracheal tube. In other procedures, however, for
example, where a patient may be sedated, but conscious and breathing on their own, the delivery of supplemental oxygen or
inspired gas may be accomplished via a mask or by nasal cannulae
(tubes placed up each nare of a patient's nose), connected to a
supply of oxygen or the desired gas composition.
Taking oxygen as one example of an inspired gas to be delivered to a person, the primary goal of oxygen supplementation
(whether mask-free or otherwise) is to enrich the oxygen
concentration of the alveolar gas, namely, the mixture of gas in the
alveoli (microscopically tiny clusters of air-filled sacs) in the lungs.
In a person with normal lung function, the level of oxygen in the
deepest portion of the alveolar sacs is essentially reflected at the
end of each "tidal volume" of exhaled gas (the volume of gas in one
complete exhalation). The gas sample measured at the end of a
person's exhalation is called the "end-tidal" gas sample.
So, for example, if a person breathes room air, room air contains 21% oxygen. When the person exhales, the end tidal gas
will have about 15% oxygen; the capillary blood has thus removed
6% of the oxygen from the inhaled gas in the alveoli, to be burned by
the body in the process of metabolism. Again, a simple goal of any
form of oxygen supplementation is to increase the concentration of
oxygen in the alveolar sacs. A convenient method of directly measuring or sampling the gas in alveolar sacs is by continuously
sampling the exhaled gas at the mouth or nose and identifying the
concentration of oxygen at the end-tidal point, a value that is
reasonably reflective of the oxygen concentration in the alveolar sacs. Thus, one can compare the effectiveness of oxygen delivery
systems by the amount that they increase the end tidal oxygen
concentration.
If a person breathes through a sealing face mask attached to
one-way valves and inhales a supply of 100% oxygen, the end tidal concentration of oxygen goes up to 90%. More specifically, once
inert nitrogen gas has been eliminated from the lungs (after pure
oxygen has been breathed for several minutes), alveolar gas will
contain about 4% water vapor and 5% carbon dioxide. The
remainder (about 90%) will be oxygen. Thus, the best oxygen
delivery systems typically increase end tidal oxygen from a baseline
of 15%, when breathing non-supplemented room air, to 90% when
breathing pure oxygen. Although sealed face-masks are relatively effective oxygen delivery systems, conscious patients, even when
sedated, often find masks significantly uncomfortable; masks
inhibit the ability of a patient to speak and cause anxiety in some
patients.
Nasal cannulae, on the other hand, do not typically cause the
level of discomfort or anxiety in conscious patients that masks do,
and thus, from a patient comfort standpoint, are preferable over
masks for the delivery of oxygen to conscious patients. Nasal cannulae are, however, significantly less effective oxygen delivery
systems than sealed face masks. Nasal cannulae generally increase
the end tidal oxygen concentration to about 40% (as compared to
90% for a sealed mask). Nasal cannulae are less effective for at least two reasons.
First, when a person inhales, they frequently breathe
through both nasal passages and the mouth (three orifices). Thus, the weighed average concentration of inhaled oxygen is
substantially diluted to the extent of mouth breathing because 21%
times the volume of air breathed through the mouth "weights down
the weighted average."
Second, even if a person breathes only through their nose, the
rate of inhalation significantly exceeds the supply rate of the nasal
cannula (typically 2-5 liters/min.) so the person still dilutes the
inhaled oxygen with a supply of 21% O2 room air. If the nasal cannula is flowing at 2 liters per minute and a person is inhaling a
liter of air over 2 seconds, the inhalation rate is 30 liters per
minute, and thus, most of the inhaled volume is not coming from
the nasal cannula, but rather from the room. Increasing the oxygen flow rate does not effectively solve this problem. First, patients
generally find increased flow very uncomfortable. Second, increased
inspired gas flow dilutes (washes away) exhaled gases like carbon
dioxide and/or exhaled vapors of intravenous anesthetics or other
drugs. When this happens carbon dioxide cannot be accurately sampled as a measure of respiratory sufficiency. Also, a drug such
as an inhalational or intravenous anesthetic, cannot be accurately
sampled as a measure of the arterial concentration of the drug from
which, for example, the level of sedation might be inferred. There is
a need in various medical procedures and treatments to monitor patient physiological conditions such as patient ventilation (the
movement of gas into and out of the lungs, typically measured as a
volume of gas per minute). If the patient does not move air into and
out of the lungs then the patient will develop oxygen deficiency (hypoxia), which if severe and progressive is a lethal condition.
Noninvasive monitoring of hypoxia is now available via pulse
oximetry. However, pulse oximetry may be late to diagnose an
impending problem because once the condition of low blood oxygen
is detected, the problem already exists. Hypoventilation is
frequently the cause of hypoxemia. When this is the case, hypoventilation can precede hypoxemia by several minutes. A good
monitor of ventilation should be able to keep a patient "out of
trouble" (if the condition of hypoventilation is diagnosed early and
corrected) whereas a pulse oximeter often only diagnoses that a
patient is now "in" trouble. This pulse oximetry delay compared to ventilatory monitoring is especially important in acute settings
where respiratory depressant drugs are administered to the patient,
as is usually the case during painful procedures performed under
conscious sedation.
Ventilatory monitoring is typically measured in terms of the
total volumetric flow into and out of a patient's lungs. One method
of effective ventilatory monitoring is to count respiratory rate and
then to measure one of the primary effects of ventilation (removing
carbon dioxide from the body). Certain methods of monitoring
ventilation measure the "effect" of ventilation (pressure oscillations,
gas flow, breath sound and exhaled humidity, heat or CO2 at the
airway). Other ventilation methods measure the "effort" of
ventilation (e.g., transthoracic impedance plethysmography, chest
belts, respiratory rate extraction from optoplethysmograms). Effort-based ventilation monitors may be less desirable because
they may fail to detect a blocked airway where the patient
generates the effort (chest expansion, shifts in blood volume, etc.)
but does not achieve the desired effects that accompany gas exchange.
There are a variety of ventilation monitors such as 1) airway
flowmeters and 2) capnometers (carbon dioxide analyzers). These monitors are used routinely for patients undergoing general
anesthesia. These types of monitors work well when the patient's
airway is "closed" in an airway system such as when the patient has
a sealing face mask or has the airway sealed with a tracheal tube
placed into the lungs. However, these systems work less well with
an "open" airway such as when nasal cannulae are applied for
oxygen supplementation. Thus, when a patient has a non-sealed
airway, the options for tidal volume monitoring are limited. With
an open airway, there have been attempts to monitor ventilation
using capnometry, impedance plethysmography, humidity, heat,
sound and respiratory rate derived from the pulse oximeter's
plethysmogram. Some of the limitations are discussed below.
Nasal capnometry is the technique of placing a sampling tube
into one of the nostrils and continuously analyzing the carbon
dioxide content present in the gas stream thereof. Nasal
capnometry is relatively effective provided that 1) the patient
always breathes through his/her nose, and 2) nasal oxygen is not
applied. More specifically, if the patient is talking, most of the exhalation is via the mouth, and frequent false positive alarms sound because the capnometer interprets the absence of carbon
dioxide in the nose as apnea, when in fact, it is merely evidence of
talking. Some devices in the prior art have tried to overcome this
problem by: manual control of sampling from the nose or mouth
(Nazorcap); supplementing oxygen outside of the nose while
sampling for CO2 up inside the nose (BCI); providing oxygen in the nose while sampling CO2 from the mouth (BCI); and supplying
oxygen up one nostril and sampling for CO2 up inside the other
nostril (Salter Labs). None of these already-existing systems
provide oxygen to both the nose and mouth or allow automatic
control of sampling from either site or account for the possibility that one nostril may be completely or partially obstructed compared
to the other one. Further, if nasal oxygen is applied to the patient,
the carbon dioxide in each exhalation can be diluted significantly by
the oxygen supply. In this case, the capnometer may interpret the diluted CO2 sample as apnea (stoppage in breathing), resulting once
again, in frequent false positive alarms. Dilution of CO2 may also
mask hypoventilation (detected by high CO2) by making a high CO2
value appear artifactually normal and thus lull the clinician into a
false sense of security, that all is well with the patient.
Impedance plethysmography and plethysmogram respiratory
rate counting also suffer drawbacks as primary respiratory
monitors. Both devices measure the "effort" of the patient (chest expansion, shifts in blood volume). Impedance plethysmography is
done via the application of a small voltage across two ECG electrode
pads placed on each side of the thoracic cage. In theory, each
respiration could be detected as the phasic change of thoracic impedance. Unfortunately, the resulting signal often has too much
noise/artifact which can adversely affect reliability. Respiratory
rate derived from the pulse oximeter's plethysmogram may not
diagnose apnea and distinguish it from complete airway
obstruction, thus misdiagnosing apnea as a normal condition (a false negative alarm state).
The arterial concentration of an inhalational or intravenous
drug or gas is clinically useful and may be inferred from the end-
tidal concentration of the drug or gas measured in the gases exhaled by the patient. The end-tidal concentration of a desired component
of the exhaled gas mixture can be monitored and used to infer the
arterial concentration. Examples of drugs and gases that can be
monitored include, among other things: propofol, xenon,
intravenous anesthetics and sedatives, and water vapor.
Various inspired gas compositions may be administered to
patients for different purposes. Oxygen diluted with air may be
used instead of pure O2 to reduce the risk of an oxygen-enriched
micro-environment that may support or promote ignition of a fire,
especially for those procedures using lasers (such as laser resurfacing of the face). An oxygen-helium mixture may be used to
reduce the resistance to flow. An oxygen/air/bronchodilator mixture
may be used to treat bronchoconstriction, bronchospasm or chronic
obstructive pulmonary disease (COPD). A mixture of O2 and water
vapor may be used to humidify and loosen pulmonary secretions.
In view of the above drawbacks to current systems for
delivering inspired gas and gas sampling, including monitoring
ventilation, there is a. need for an improved combined system to
accomplish these functions.
SUMMARY OF THE INVENTION
One of the purposes of the current invention is to increase the
alveolar concentration of an inspired gas, such as oxygen, without
the requirement for a patient to wear a face mask. This is done by, among other things: a) determining the patient's breath phase,
namely whether the person is in the inhalation or exhalation phase of their respiratory cycle; and b) delivering a higher flow of inspired
gas during the inhalation part of the respiratory cycle thereby
making this higher flow of inspired gas acceptable to patients. In one aspect of the invention the inspired gas flow may be provided to
all three respiratory orifices (i.e., both nostrils and the mouth) or
directly in front of the mouth, during the inhalation cycle. Thus,
dilution of inhaled gas by room air at an inhalation portal is
reduced.
A second purpose of the invention is to more effectively sample exhaled gases, such sampling could be used, for example, to
monitor patient ventilation, in combination with mask-free delivery of inspired gas to the patient. In this aspect, the invention includes
placing pressure lumens and gas-sampling lumens inside, or near,
at least one of a patient's nostrils and, in some embodiments, the mouth. The pressure lumens are connected to pressure transducers
that in turn are connected to a controller or processor running custom software algorithms for determining breath phase
(inhalation or exhalation) and rate. The pressure samples from the
respective lumens are compared with one another to determine the
primary ventilatory path. The gas sampling tubes may be
connected to gas analyzers or monitors, e.g., CO2 analyzers, that
measure the level of a gas or drug in the exhaled gas.
Other aspects of the invention will be apparent from the
description below.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a side, cut out view of the disposable portion of
the apparatus placed on a patient in accordance with one embodiment of the invention.
FIG. 2 shows a perspective exterior view of the disposable
portion of the apparatus in accordance with one embodiment of the invention.
FIG. 3 is a blow-up view showing the lower, middle and cover
portions of the disposable portion of the apparatus in accordance
with one embodiment of the invention.
FIG. 4 shows an embodiment of the disposable portion of the
apparatus with an oral collection chamber in accord with one
embodiment of the invention.
FIG. 5A is a schematic diagram of a gas delivery and gas sampling system in accordance with one embodiment of the
invention.
FIG. 5B is a schematic diagram of a gas delivery and gas
sampling system in accordance with an alternative embodiment of the invention. FIG. 6 is a schematic diagram of pressure
transducer circuitry in one embodiment of the invention.
FIG. 7 is a diagram of a pressure waveform during a
respiration cycle used in one method of the invention.
FIG. 8 is a flow chart of a preferred embodiment of one method of the invention.
FIG. 9 is a schematic diagram of a gas delivery and gas
sampling system in accordance with an alternative embodiment of
the invention.
FIG. 10 is a perspective diagram of an alternative embodiment of an oronasal gas diffuser and gas sampling device in accord with the invention.
FIG. 11 is a side-elevation frontal view of the device shown in
FIG. 10.
FIG. 12 is a plan view of the bottom of the device shown in
FIG. 10. FIG. 13 is a side-elevation back view of the device shown in
FIG. 10.
FIG. 14 is a cross-sectional view of the tubing that connects
the device in FIG. 10 to the circuitry in FIG. 9.
FIG. 15 is a view of a connector that interfaces the machine
end of the extruded tubing of FIG. 14 to a medical device.
DESCRIPTION OF PREFERRED EMBODIMENTS
Single Capnometer Embodiment
The concept of the invention will now be described using, merely by way of example, supplemental oxygen as the inspired gas
mixture and gas sampling of carbon dioxide in the patient's
exhalations. It should be understood that the concept of the
invention is not limited to supplemental O2 administration and CO2 sampling.
FIG. 1 shows a cut-out view of the disposable portion 4 of an
apparatus in accordance with the invention placed on a patient 10.
The apparatus provides for the mask-free delivery of
supplemental oxygen gas to the patient combined with the monitoring of patient ventilation. Oxygen gas is supplied to the
patient from an O2 supply tube 12 and exits portion 4 from a diffuser grid 14 in housing 16 (shown in more detail in FIG. 2).
Diffuser grid 14 blows diffused oxygen into the immediate area of
the patient's nose and mouth. Two thin lumens (tubes) are
mounted adjacent one another to portion 4 and placed in one of the
patient's nostrils (nasal lumens 18). Another two thin lumens are also mounted adjacent to one another to portion 4 and placed in
front of the patient's mouth (oral lumens 20).
Of nasal lumens 18, one lumen is a pressure lumen for
sampling the pressure resulting from a patient's nose breathing and
the other lumen continuously samples the respiratory gases so they
may be analyzed in a capnometer to determine the concentration of
carbon dioxide. This arrangement is essentially the same for oral
lumens 20, namely, one lumen is a pressure lumen (samples
pressure in mouth breathing) and the other lumen continuously
samples the respiratory gases involved in mouth breathing.
Nasal lumens 18 and oral lumens 20 are each connected to
their own pneumatic tubes, e.g., 22, which feed back the nasal and
oral pressure samples to pressure transducers (not shown) and
which feed back the nasal and oral gas samples to a capnometer (not shown). All of portion 4; lumens 18, 20; oxygen supply tubing 12 and feedback tubing 22 are disposable (designed to be discarded,
e.g., after every patient use), and preferably constructed of pliable
plastic material such as extruded polyvinyl chloride.
As shown in FIG. 2, lumens 18, 20 and tubings 12 and 22,
although shown as a portion cut-out in FIG. 1 in a preferred
embodiment, are housed in cover 30. Also, in FIG. 2, nasal lumens
18 (including pressure lumen 28 and gas sampling lumen 26) are
preferably formed from a double-holed, single-barrel piece. Oral
lumens 20 (which include pressure lumen 32 and gas sampling lumen 34) are preferably formed from a double barrel piece.
Diffuser grid 36 is formed in cover 30 and functions as an oxygen
diffuser which releases a cloud of oxygen into the immediate oral
and nasal area of the patient 10.
FIG. 3 shows disposable portion 4 including cover 30 in more detail in cut-out fashion. Specifically, lower portion 110, formed
from a suitably firm, but not rigid, plastic, has an opening 112 for
insertion of oxygen supply tube 12. Slot 114 in portion 110 receives
the oxygen gas from the tube 12, retains it, and forces it up through opening 148 in middle portion 112. Middle portion 112 is affixed to
lower portion 110 lying flat on portion 110. From opening 148, the
oxygen gas travels into cover 130 (affixed directly onto middle
portion 112) and travels lengthwise within cover 130 to the diffuser portion, whereupon the oxygen exits cover 130 through diffuser grid
136 into the immediate vicinity of the patient's nose and mouth in a
cloud-like fashion. It is preferable to supply oxygen flow to all three
respiratory orifices (both nostrils and mouth) to increase the
concentration of oxygen provided to the patient. By providing flow
to all three orifices, dilution of inhaled gas at an inhalation portal by pure room air is reduced. Also, a diffused stream such as that
created by grid 136 is a preferred embodiment for the oxygen
stream delivered to the patient. This is because a stream of oxygen
delivered through a single lumen cannula is typically uncomfortable
at the higher flow rates necessary for sufficient oxygen delivery.
Further, at those flow rates, a single lumen can create an
undesirable Bernoulli effect. It is noted that an alternative to the
diffuser grid 136 is a cup-shaped or other chamber which receives
the O2 jet stream and includes a foam or filler paper section for
diffusing the jet stream of O2. As is also shown in FIG. 3, feedback tubing 22 enters lower
portion 110 at openings 122. At opening 122 begin grooves 146 and
140 formed in lower portion 110 each for receiving the feedback
pressure sample from lumens 128 and 132. At opening 122 begin grooves 144 and 142, formed in lower portion 110 each for receiving
the feedback CO2 sample from lumens 126 and 134. Grooves 146,
144, 140 and 142, all formed in lower portion 110, connect at one end to their respective sampling lumens (128, 126, 132 and 134) and
at their other end to feedback tubing 22; middle portion 112 lies flat
on and affixed to portion 110 such that the grooves 146, 144, 140
and 142 form passageways for the respective feedback samples. As can be seen, when assembled, portions 130, 112 and 110 together
form whole disposable piece 4, shown perspectively in FIG. 2.
FIG. 4 shows a preferred embodiment of disposable portion 4
(here portions 110 and 112 are shown affixed to one another) with
an oral sample collection chamber 210 fitting over oral lumens 220 (nasal lumens are shown at 218 and the opening for the oxygen
supply tube is shown at 212). Oral sample collector 210 is
preferably constructed of plastic and creates a space in chamber 214
that collects a small volume of gas the patient has breathed orally. That volume of gas is then sampled by lumens 220 and fed back for
analysis through the respective pressure and CO2 feedback tubing
to pressure transducers and the capnometer described above. Collector 210 thus acts as a storage container for better sampling of
the oral site. It also serves as a capacitor for better monitoring of
oral site pressure (exhalation contributes to volume and pressure
increases, while inhalation removes gas molecules from volume 214
and pressure decreases).
In one preferred embodiment, collector 210 is provided in a variety of sizes and shapes to collect different volumes of air or to facilitate different medical procedures which may be performed in
or near the mouth. In another preferred embodiment collector 210
is adjustable in that it is capable of sliding over lumens 220 to
enable positioning directly over the mouth's gas stream. In a
further embodiment, lumens 220 are themselves also slidably
mounted to portion 222 so as to be extendable and retractable to
enable positioning of both the lumens and collector directly in front
of the oral gas stream.
The present invention generally provides that in the event
that positive pressure ventilation has to be applied via face mask, it
should be possible to leave the apparatus of the invention in place on the person to minimize user actions during an emergency. Thus,
the apparatus of the invention allows a face mask to be placed over
it without creating a significant leak in the pillow seal of the face
mask. The material of the apparatus in contact with the face is preferably soft (e.g., plasticized PVC, etc.) and deformable. This
prevents nerve injury, one of the most common complications of
anesthesia, which is often caused by mechanical compression or
hyperextension that restricts or shuts off the blood supply to nerves.
FIG. 5A shows a schematic circuit diagram of a preferred
embodiment of the oxygen delivery and gas sampling system of the invention. As described above, disposable portion 304 includes
nasal lumens which sample a nasal (nares) volume 318 of gas
breathed through the patient's nostril; an oral sample collector
which creates an oral volume of gas 320 effecting sampling of gas breathed through a patient's mouth; and an oxygen diffuser 336
which enriches the immediate breathing area of a patient with
oxygen, increasing the patient's fraction of inspired oxygen and
thereby increasing the patient's alveolar oxygen levels. The diffuser
336 ensures that a high rate of oxygen flow is not uncomfortable for
the patient.
Oxygen gas is supplied to diffuser 336 from an oxygen supply
(O2 tank or in-house oxygen). If the supply of O2 is from an in-house
wall source, DISS fitting 340 is employed. The DISS fitting 340 (male body adaptor) has a diameter indexed to only accept a
Compressed Gas Association standard oxygen female nut and
nipple fitting. A source pressure transducer 342 monitors the
oxygen source pressure and allows custom software running on a
processor (not shown) to adjust the analog input signal sent to proportional valve 346 in order to maintain a user-selected flow rate
as source pressure fluctuates. Pressure relief valve 348 relieves
pressure to the atmosphere if the source pressure exceeds 75 psig.
Proportional valve 346 sets the flow rate of oxygen (e.g., 2.0 to 15.0 liters per minute) through an analog signal and associated driver circuitry (such circuitry is essentially a voltage to current converter
which takes the analog signal to a dictated current to be applied to
the valve 346, essentially changing the input signal to the valve in
proportion to the source pressure, as indicated above). It is noted that flowrates of 2.0 and 15.0 L/min could also be accomplished by 2
less expensive on/off valves coupled with calibrated flow orifices instead of one expensive proportional flow control valve.
Downstream pressure transducer 350 monitors the functionality of
proportional valve 346. Associated software running on a processor
(not shown) indicates an error in the delivery system if source
pressure is present, the valve is activated, but no downstream pressure is sensed. As described above, the nares volume 318 and
oral collection volume 320 are fed back to the capnometer 352 via a
three-way valve 354. The capnometer 352 receives the patient
airway gas sample and monitors the CO2 content within the gas sample. Software associated with capnometer 352 displays
pertinent parameters (such as a continuous carbon dioxide graphic
display known as a capnogram and digital values for end-tidal CO2
and respiration rate) to the user. A suitable capnometer may be that manufactured by Nihon Kohden (Sj5i2) or Ca dioPulmonary
Technologies (CO2WFA OEM). Three-way valve 354 automatically
switches the sample site between the oral site and the nasal site
depending on which site the patient is primarily breathing through. This method is described in more detail below, but briefly, associated software running on a processor (not shown) switches the
sample site based on logic that determines if the patient is breathing through the nose or mouth. It is preferable to have a
short distance between the capnometer and valve 354 to minimize
dead space involved with switching gas sample sites.
Also as described above, the nares volume 318 collected is fed
back to a nasal pressure transducer 356 and nasal microphone 358.
Transducer 356 (such as a Honeywell DCXL01DN, for example)
monitors the pressure in the nares volume 318 through the small
bore tubing described above. Associated software running on a
processor (not shown) determines through transducer 356 if the
patient is breathing primarily through the nose. Associated offset, gain and temperature compensation circuitry (described below)
ensures signal quality. Nasal microphone 358 monitors the
patient's breath sounds detected at the nasal sample site.
Associated software allows the user to project sound to the room
and control audio volume. Output from nasal microphone 358 may
be summed with output of the oral microphone 360 for a total
breath sound signal. In an additional embodiment the breath sound
signals are displayed to the user and/or further processed and analyzed in monitoring the patient's physiological condition.
Oral pressure transducer 362 (such as a Honeywell
DCXL01DN, for example) monitors pressure at the oral collection
volume 320 through the small bore tubing described above.
Associated software running on a processor (not shown) determines
via pressure transducer 362 if the patient is primarily breathing through the mouth. Offset gain and temperature compensation
circuitry ensure signal quality. Oral microphone 360 operates as
nasal microphone 358 described above that amplifies and projects
breath sounds to the room. Alternatively, a white noise generator
reproduces a respiratory sound proportional to the amplitude of the respiratory pressure and encoded with a sound (WAV file) of a
different character for inhalation versus exhalation so that they
may be heard and distinguished by a care giver in the room.
A dual chamber water trap 364 guards against corruption of
the CO2 sensors by removing water from the sampled gases. Segregated chambers collect water removed by hydrophobic filters
associated with the nasal and oral sites. This segregation ensures
that the breathing site selected as the primary site is the only site
sampled. The disposable element 304 is interfaced to the non- disposable elements via a single, multi-lumen connector 344 that
establishes five flow channels in a single action, when it is snapped
to the medical device containing the non-disposable equipment.
FIG. 5B shows an additional embodiment of the system circuit of the present invention, including a gas sample bypass circuit which keeps the gas sample at the oral and nasal sites
flowing at the same rate, regardless of whether the site is being
sampled by the capnometer or bypassed. Specifically, nasal diverter
valve 555 switches the nasal gas sample site between the
capnometer and the bypass line. Activation of the valve 555 is
linked to activation of oral diverter valve 557 in order to ensure that
one sample site is connected to the bypass line while the other
sample site is connected to the capnometer. This allows two states:
1) the oral gas sample site fed back to the capnometer, with the
nasal gas sample site connected to the bypass; and 2) the nasal gas
sample site fed back to the capnometer with the oral gas sample site on bypass. As described above, the control software switches the
gas sample site based on logic that determines if the patient is
breathing through the nose or mouth. Oral diverter valve 557
switches the oral gas sample site between the capnometer and the bypass line and operates as described with respect to nasal diverter
valve 555.
Bypass pump 559 maintains flow in the bypass line 561 that
is equivalent to flow dictated by the capnometer (e.g., 200 cc/min.).
The pump 559 also ensures that the gas sample sites are synchronized with one another so that the CO2 waveform and
respiration rate calculations are not corrupted when gas sample
sites are switched. Flow sensor 563 measures the flow rate
obtained through the bypass line 561 and provides same to
electronic controller 565 necessary for flow control. Controller 565
controls the flow of pump 559.
As can be seen from FIG. 5B, balancing the flow between the
active gas sample line and the bypass line (e.g., maintaining a flow
in the bypass equivalent or near equivalent to the flow within the
CO2 sampling line, e.g., 200 cc/min) is desired. This prevents corruption of the CO2 waveform and respiration rate calculations in
the event one site became occluded such that the bypass and
capnometer lines flowed at different rates.
FIG. 6 shows a schematic of the electronic circuitry
associated with pressure transducers 356 and 362. Such circuitry
includes a pressure sensor 402, a hi-gain amplifier 404, a
temperature compensation and zeroing circuit 406 and a low pass
filter 408. The gain and temperature zeroing circuit ensure signal quality for the pressure transducer output. Depending on the
signal to noise ratio of the pressure transducer 402, the low pass
filter 408 may be optional.
FIG. 7 is a diagram of the pressure reading (oral or nasal)
during a typical respiration cycle with thresholds A, B, C and D
identified in accordance with the preferred method of the invention. As is shown, as exhalation 706 begins, the pressure becomes positive, eventually reaching a peak then dropping back to zero
(atmospheric pressure) as the exhalation completes. The beginning
of inhalation 708 is indicated by the pressure becoming negative
(sub-atmospheric). The pressure will become more negative during
the first portion of inhalation then trend back towards zero as
inhalation ends.
The control software of the present invention defines an
upper and a lower threshold value 702, 704, respectively. Both are
slightly below zero, with the lower threshold 704 being more
negative than the upper threshold 702. During each respiration
cycle the software determines when the thresholds 702, 704 are
crossed (points A, B, C, and D, FIG. 7) by comparing the pressures
to one of the two thresholds. The crossings are expected to occur in
sequence, i^, first A, then B followed by C, and finally D. An O2
source valve is turned up (e.g., to 10-15 liters/min of flow) when
point A, 710, is reached and turned down (e.g., to 2-3 liters/min of flow) when C, 712, is reached, thus providing the higher oxygen flow
during the majority of the inhalation phase.
To determine when the threshold crossings occur, the
software examines the pressures from the oral and nasal pressure
sensors at periodic intervals, e.g., at 50 milliseconds (see FIG. 8,
step 820). During each examination, the software combines the
oral and nasal pressures and then compares the combined pressure
to one of the two thresholds as follows.
As shown by the flowchart of FIG. 8, when the software
begins execution, it reads the nasal and oral pressures, step 802, and awaits a combined pressure value less tharJthe upper threshold
(point A), step 804. When this condition is met, the software turns
up the O2 valve, step 806, to a higher desired flow (e.g., 10-15
liters/min) then begins looking for a combined pressure value less
than the lower threshold (point B), step 808. When this occurs the
software waits for a combined pressure value that is greater than
the lower threshold (point C). When this value is read, the O2 is
turned down to the lower desired flow rate (e.g., 2-3 liters/min), step
810, and the software awaits a pressure value that exceeds the upper threshold (point D). Once this value is read, the cycle begins
again for the next breath. In the case of oxygen, the invention may
thus increase end tidal oxygen concentrations from the baseline
15% (breathing room air) up to 50-55%. Whereas this may not be as
effective as face mask oxygen supplementation, it is significantly
better than the prior art for open airway oxygen supplementation
devices.
Also, instead of completely shutting off inspired gas flow during exhalation, the invention selects a baseline lower flow of
inspired gas, e.g., 2 L/min, so that the flow interferes minimally with the accuracy of exhaled gas sampling. The non-zero inspired
gas flow during exhalation enriches the ambient air around the
nose and mouth that is drawn into the lungs in the subsequent
inhalation. Further, in the event that O2 is the inspired gas and that the software malfunctions such that the algorithm stays stuck
in the exhalation mode, a non-zero baseline flow of O2 will ensure
that the patient breathes partially O2-enriched room air rather than
only room air.
As described above, a capnometer may be used to provide
information such as end-tidal CO2 and respiration rate by
continually sampling the level of CO2 at a single site. Since breathing can occur through the nose, mouth, or both, the software
must activate valve 354 (FIG. 5A) or valves 555 and 557 (FIG. 5B), that switch the capnometer-sampling site to the source providing
the best sample, i.e., mouth or nose.
As is also shown in FIG. 8, the software determines the best
sampling site by examining the oral and nasal pressure readings at
periodic intervals. During each examination, the current and prior three oral pressure values are compared to the corresponding nasal
pressure values. If the combined nasal pressures exceed the combined oral pressures by more than a factor of three, the
capnometer sample is obtained at the nose. If the combined oral
pressures exceed the combined nasal pressures by more than a factor of three, the sampling occurs at the mouth.
It is further noted that the gas sampling lumens may be
connected together at a switching valve to minimize the number of
gas analyzers required. Via the switching valve, the gas sampling
lumen connected to the primary ventilatory path is routed to the
gas analyzer. Additionally, in some aspects of the invention, the
user sees a display from one gas analyzer. For example, for a capnometry application, the CO2 tracing that has the highest
averaged value (area under the curve over the last n seconds, e.g.,
15 seconds) is displayed. Because the present invention measures
the "effect," La., the CO2 and airway pressure variations with each
breath, it would not fail to detect a complete airway obstruction. Multiple Capnometer Embodiment
An alternative embodiment of the invention uses two
capnometers as shown in FIG. 9, 912 and 914. Pressure transducer
906 monitors the pressure at nose tap 938. Pressure transducer 908 monitors the pressure at nose tap 940. Each nose tap 938 and 940
samples the pressure in one of the patient's nares. Pressure
transducers 906 and 908 can be momentarily connected to
atmosphere for zeroing purposes via valves 904 and 902
respectively. Pressure is not monitored at the mouth. The primary nasal ventilatory path is determined from analysis of the pressure
trace at each nares. The nare whose pressure trace exhibits the
larger amplitude of pressure oscillation is considered to be the
primary nasal ventilatory path.
Gas sample lumens are placed at both nares and at the
mouth. The oral gas sample lumen 932 is directly connected to the oral capnometer 914. The nasal capnometer 912 can be connected
to either of the nasal gas sampling lumens 934 or 936 via a
switching valve 910. Once the pressure transducers and the software determine the primary nasal ventilatory path, the
switching valve routes the gas sample from the primary nasal
ventilatory path to the nasal capnometer 912. Thus, exhaled gas is
sampled continuously from either the right or left nasal passage.
The software analyzes the sum of the pressures sampled from
the two nasal orifices to determine whether the patient is inhaling or exhaling. Obviously, different algorithms may be possible like
determining the breath phase from only the pressure trace at the
primary nasal ventilatory path, instead of adding the pressures
from both nares. Software running on a processor (not shown)
opens a valve 922 connected to an oxygen source so that oxygen flow
is high (e.g., 15 L/min) during the inhalation phase of the patient's
breathing. A high pressure relief valve 918 relieves pressure if the
O2 supply pressure exceeds 75 psig. A pressure transducer 920 monitors the O2 supply pressure such that the software can adjust
the opening of the valve 922 to compensate for O2 supply pressure
fluctuations. A pressure relief valve 924 downstream of the valve
922 prevents pressure buildup on the delivery side. Components
918, 920, 922 and 924 are mounted on a gas manifold 916 with
internal flow passages (not shown) to minimize the number of
pneumatic connections that have to be manually performed.
An audio stimulus generated by sub-system 926 is used to
prompt the patient to perform a specific action like pressing a
button as a means of assessing responsiveness to commands as an
indirect measure of patient consciousness. This automated responsiveness test is useful in a conscious sedation system like, for
example, that described in U.S. patent application Serial No.
09/324,759 filed June 3, 1999.
The oronasal piece 1000 in FIG. 10 is intended for use with the circuit in FIG. 9. A pressure sampling lumen 1008 and a gas sampling lumen 1006 are contained within left nostril insert 1004
that fits into the left nare of the patient. A pressure sampling
lumen 1058 and a gas sampling lumen 1056 are contained within
right nostril insert 1054 that fits into the right nare of the patient.
A multiplicity of holes 1012 diffuse O2 near the region of the nares.
A similar multiplicity of holes 1026 (FIG. 12) diffuse O2 near the
region of the mouth, to account for the possibility of mouth
breathing. The oronasal piece 1000 is held onto the patient's face via an adjustable loop of cord or elastic band 1014 that is designed
to be rapidly adjusted to the patient. A single cord or elastic band is
made to form a loop by passing both cut ends via an adjustment
bead 1018. The loop is attached in one motion to bayonet-type
notches 1020 on oronasal piece 1000 that securely hold the cord in
place on the oronasal piece while it is being wrapped around the
back of the patient's head. The adjustment bead 1018 is then slid
along the loop to adjust the tension on the cord. Once adjusted, the loop is then released over the stud 1016 such that the stud tends to
splay the two pieces of cord apart, thus locking the adjustment bead
to prevent inadvertent loosening of the adjustment bead. The gas
sample lumen 1024 (FIG. 11) is contained within protuberance 1022 which is designed to stick out into the stream of gas flowing to and from the mouth.
Referring now to FIG. 13, lumen 1038 on the oronasal piece
1000 is internally connected to the gas sample lumen 1006 (FIG. 10)
for the left nare. Lumen 1036 (FIG. 13) on the oronasal piece 1000 is internally connected to the oral gas sample lumen 1024 (FIG. 11).
Lumen 1034 (FIG. 13) on the oronasal piece 1000 is internally
connected to the pressure sampling lumen 1008 (FIG. 10) for the
left nare. Lumen 1030 (FIG. 13) on the oronasal piece 1000 is internally connected to the gas sample lumen 1056 (FIG. 10) for the right nare. Lumen 1028 (FIG. 13) on the oronasal piece 1000 is
internally connected to the multiplicity of holes 1012 and 1026
(FIGS. 10 and 12) that allow O2 to diffuse into the regions close to
the nose and mouth. Lumen 1032 (FIG. 13) on the oronasal piece
1000 is internally connected to the pressure sampling lumen 1058
(FIG. 10) for the right nare. The details of the internal flow passages in oronasal piece 1000 to accomplish the above connections
will be evident to one skilled in the art.
Referring to FIG. 14, the oronasal piece 1000 of FIG. 10 is
connected to the circuit of FIG. 9 via the extruded tear-apart tubing
of FIG. 14. The extruded tubing contains seven lumens grouped in
three clusters (1142, 1144 and 1146) that can be separated from
each other by manually tearing along the tear lines 1143 and 1145.
Lumen 1130 in cluster 1142 channels the flow of O2 to the oronasal
piece and is of larger bore to accommodate the high flow of O2 and present minimal flow resistance. Lumen 1128 in cluster 1146
carries the audio stimulus that prompts the patient to squeeze a
button as part of an automated responsiveness test (ART) system.
Lumen 1132 in the middle of cluster 1144 carries the oral gas
sample. Lumens 1138 and 1134 in cluster 1142 carry the pressure and gas samples from one nasal insert. Lumens 1140 and 1136 in
cluster 1144 carry the pressure and gas samples from the other
nasal insert. The cross-section of each cluster is shaped like an aerofoil to adapt to the indentation of the facemask pillow seal and
the cheek of the patient when a facemask is placed over the
separated clusters. The lumens are arranged such that the larger bore lumens are in the middle of each cluster, taking advantage of
the aerofoil like cross-section of each cluster.
An additional feature of the invention is that the pneumatic
harness (shown in cross-section in FIG. 14) can be connected to a
standard, male, medical O2 barbed outlet connector commonly referred to as a "Christmas tree," so that the oronasal piece of the invention can also be used post-procedurally to deliver O2-enriched
air to the patient. Another feature of the invention is that the
pneumatic harness of FIG. 14 can be snapped onto a medical device
with a single action. To accomplish both design objectives, the connector of FIG. 15 is used to adapt the pneumatic harness of FIG.
14 for connection to a medical device. The pneumatic harness of
FIG. 14 is mounted onto adapter 1148 using seven male ports like
ports 1150 and 1152. Port 1152 carries the oxygen inflow and port 1150 pipes in the audio stimulus. The adapter 1148 has a tapered
inlet connected to the O2 delivery lumen 1130 (FIG. 14). The
tapered inlet is made of soft material and is designed to mate to a
standard male O2 barbed connector known as a Christmas tree.
The connector snaps into a socket on the medical device to establish
seven airtight pneumatic connections with only one action. Tapered male port 1158 on the medical device delivers oxygen into lumen
1130 via port 1152. Port 1156 brings in the pressure signal from
nose pressure tap 2. Pegs 1154 allow the multi-lumen connector
1148 to be held in tightly and securely once snapped into the
medical device to prevent accidental disconnection.
The above-described systems and methods thus provide improved delivery of inspired gas and gas sampling, including CO2
sampling, without use of a face mask. The system and method may
be particularly useful in medical environments where patients are
conscious (thus comfort is a real factor) yet may be acutely ill, such
as in hospital laboratories undergoing painful medical procedures,
but also in the ICU, CCU, in ambulances or at home for patient-
controlled analgesia, among others. It should be understood that
the above describes only preferred embodiments of the invention. It
should also be understood that while the preferred embodiments discuss gas sampling, such as CO2 sampling and analysis, the
concept of the invention includes sampling and analysis of other
medical gases and vapors like propofol, oxygen, xenon and intravenous anesthetics. It should further be understood that
although the preferred embodiments discussed address
supplemental O2 delivery, the concept of the invention is applicable
to delivery of pure gases or mixtures of gases such as 02/helium,
02/air, and others.
Claims (79)
- WHAT IS CLAIMED: 1. A method for supplying an inspired gas to a person, the methodcomprising the steps of: a) determining whether the person is inthe exhalation or inhalation phase of a respiratory cycle; and b) delivering an increased flow of inspired gas to the person during theinhalation phase of the respiratory cycle.
- 2. The method of claim 1, wherein the inspired gas includes puregas.
- 3. The method of claim 2, wherein the pure gas includes oxygen.
- 4. The method of claim 1, wherein the inspired gas includes a gasmixture.
- 5. The method of claim 4, wherein the gas mixture includes amixture of oxygen and air.
- 6. The method of claim 4, wherein the gas mixture includes a mixture of oxygen and nitrogen.
- 7. The method of claim 4, wherein the gas mixture includes amixture of oxygen and water vapor.
- 8. The method of claim 4, wherein the gas mixture includes amixture of oxygen and bronchodilators.
- 9. The method of claim 4, wherein the gas mixture includes a mixture of oxygen and helium.
- 10. The method of claim 1, wherein the inspired gas may be releasedto the ambient environment.
- 11. The method of claim 1 also comprising the step of determiningthe primary respiratory site; and sampling the person's breath gasstream at least in accordance with the determination of the primary respiratory site.
- 12. The method of claim 11 whereby the gas stream at the mouth iscontinuously sampled, in addition to sampling at the determinedprimary respiratory site.
- 13. The method of claim 11, wherein the step of sampling the breath gas stream includes the step of monitoring the ventilation of theperson at least in accordance with the determination of the person'sprimary respiratory site.
- 14. The method of claim 13 whereby the gas stream at the mouth is continuously sampled, in addition to sampling at the determinedprimary ventilatory site.
- 15. The method of claim 1 wherein the inspired gas is delivered tothe person in the area of the person's nose and mouth.
- 16. The method of claim 1, wherein the inspired gas is delivered tothe person in the area in front of the person's mouth.
- 17. The method of claim 1 wherein the determining of whether theperson is in the exhalation or inhalation phase is accomplished byanalyzing the pressure in the person's breath gas stream.
- 18. The method of claim 17 also comprising the step of monitoring the respiratory rate in accord with the pressure analysis.
- 19. The method of claim 17 also comprising the step of monitoringthe inspiratory/expiratory time ratio in accord with the pressure analysis.
- 20. The method of claim 17, wherein the pressure in the person'sbreath gas stream is determined by sampling pressure at at leastone respiratory site.
- 21. The method of claim 17, wherein the determining of whether theperson is in the exhalation or inhalation phase is accomplished byanalyzing the humidity in the person's breath gas stream.
- 22. The method of claim 21 also comprising the step of monitoringthe respiratory rate in accord with the humidity analysis.
- 23. The method of claim 21 also comprising the step of monitoringthe inspiratory/expiratory time ratio in accord with the humidityanalysis.
- 24. The method of claim 17, wherein the determining of whether theperson is in the exhalation or inhalation phase is accomplished byanalyzing the temperature in the person's breath gas stream.
- 25. The method of claim 24 also comprising the step of monitoringthe respiratory rate in accord with the temperature analysis.
- 26. The method of claim 24 also comprising the step of monitoringthe inspiratory/expiratory time ratio in accord with the temperature analysis.
- 27. The method of claim 11, wherein the determining of the primaryrespiratory site is accomplished by sampling pressure at the respiratory sites and comparing said pressures.
- 28. The method of claim 11, wherein the step of sampling theexhaled gas stream includes sampling the level of CO2 in theperson's breath gas stream.
- 29. The method of claim 13, wherein the monitoring of theventilation is accomplished by measuring the CO2 levels in theperson's breath stream.
- 30. The method of claim 29, wherein the monitoring of theventilation is accomplished by measuring the end-tidal CO2 value.
- 31. The method of claim 29, wherein the monitoring of the ventilation is accomplished by determining the area under theexpired CO2 time pilot.
- 32. The method of claim 1 also comprising the step of delivering adecreased flow of inspired gas to the patient during exhalation.
- 33. The method of claim 11, wherein the step of sampling the breathgas stream includes monitoring the level of a drug in the person'sbreath gas stream.
- 34. The method of claim 33, wherein the drug is an intravenous anesthetic.
- 35. The method of claim 33 wherein the drug is propofol.
- 36. The method of claim 11, wherein the sampled gas is xenon.
- 37. An apparatus that delivers inspired gas to a person comprising:a) an inspired gas delivery device; b) at least one respiratory sitesampling device which samples the pressure at at least onerespiratory site; c) and wherein the respiratory site sampling deviceis connected to a pressure analyzer which determines the phase ofthe person's respiration cycle; d) and wherein the inspired gasdelivery device is connected to a controller that modulates the flowof inspired gas in accordance with the phase of the person'srespiratory cycle.
- 38. The apparatus of claim 37, wherein the respiratory site sampling device comprises at least one nasal sampling device which samplesthe pressure in the person's nasal airway and an oral samplingdevice which samples the pressure in the person's oral airway.
- 39. The apparatus of claim 37, wherein the controller delivers a higher flow of inspired gas during the inhalation phase of theperson's respiratory cycle.
- 40. The apparatus of claim 38, wherein at least two of the nasal andoral sampling devices are connected to a pressure comparator whichdetermines the person's primary respiratory site.
- 41. The apparatus of claim 37 also comprising a gas samplingdevice.
- 42. The apparatus of claim 41, wherein the gas sampling device is a capnometer.
- 43. The apparatus of claim 41, wherein the gas sampling devicecomprises a nasal gas sampling device and an oral gas samplingdevice and wherein the controller selects at least the gas streamfrom the primary respiratory site for monitoring.
- 44. The apparatus of claim 43, wherein the oral and nasal gassampling devices are capnometers.
- 45. The apparatus of claim 37 also comprising a flow control valveand wherein the controller runs software that indicates an error toa user if while the flow control valve is open, the controller detectspressure at the source of inspired gas but fails to detect pressure downstream of the flow control valve.
- 46. The apparatus of claim 37 also comprising an auditory breathsonification device that amplifies breath sounds.
- 47. The apparatus of claim 46, wherein the auditory breathsonification device is a microphone that amplifies actual breathsounds.
- 48. The apparatus of claim 46, wherein the auditory breathsonification device comprises a white noise generator that providessimulated breath sounds.
- 49. The apparatus of claim 48, wherein said simulated breathsounds distinguish between inhalation and exhalation breath sounds.
- 50. The apparatus of claim 41, wherein the gas sampling devicesamples CO2 gas.
- 51. The apparatus of claim 41, wherein the gas sampling devicesamples xenon gas.
- 52. The apparatus of claim 41, wherein the gas sampled is a drug.
- 53. The apparatus of claim 52, wherein the drug is an intravenousanesthetic.
- 54. The apparatus of claim 52, wherein the drug is propofol.
- 55. The apparatus of claim 37, wherein the inspired gas deliverydevice comprises a diffuser.
- 56. The apparatus of claim 37, wherein the controller reduces theflow of inspired gas during the exhalation phase.
- 57. A method for delivering an inspired gas, the method comprisingthe steps of: a) determining the breath phase; b) delivering a higherflow of inspired gas during the inhalation phase; and c) monitoringgases in the breath gas stream.
- 58. The method of claim 57 also comprising the step of determining at least one of the breath rate and inspiratory/expiratory time ratio.
- 59. The method of claim 57, wherein the step of determining at leastone of the breath phase, breath rate and inspiratory/expiratory timeratio is accomplished by analyzing the pressure waveform at at least one respiratory site.
- 60. The method of claim 57, wherein the step of determining at least one of the breath phase, breath rate and inspiratory/expiratory timeratio is accomplished by monitoring the humidity at at least onerespiratory site.
- 61. The method of claim 57, wherein the step of determining at least one of the breath phase, breath rate and inspiratory/expiratory timeratio is accomplished by monitoring the temperature at at least onerespiratory site.
- 62. The method of claim 57 also comprising the step of reducing theflow of inspired gas during the exhalation phase.
- 63. The method of claim 57, wherein the monitoring of exhaled gasis performed during a period of low gas flow in the exhalationphase.
- 64. The apparatus of claim 37 also comprising a plurality of lumens which effect one or more of delivering of inspired gas, respiratorysite sampling and gas sampling and wherein said lumens areaffixed to one another along separable tear lines.
- 65. The apparatus of claim 64, wherein the lumen thataccommodates the flow of inspired gas is of larger circumferencethan the other lumens.
- 66. An apparatus according to claim 64 wherein one of said lumens is a stimulus channel that carries an auditory prompt to the person.
- 67. A pneumatic harness for a medical device comprising a pluralityof lumens grouped in one or more clusters, said clusters being manually separable from one another.
- 68. The pneumatic harness of claim 67, wherein the harness alsocomprises tear lines to permit separation of the lumens from oneanother.
- 69. The pneumatic harness of claim 67, wherein at least one of the lumens is larger than the other lumens.
- 70. The pneumatic harness of claim 67, wherein the cross section ofeach cluster is of aerofoil shape.
- 71. The pneumatic harness of claim 67 also comprising a connector that permits delivery of supplemental oxygen from standardmedical oxygen connectors using an oronasal piece.
- 72. The pneumatic harness of claim 67 also comprising an adapterthat connects the pneumatic harness to a medical device.
- 73. A method of determining which of the two nares is lessobstructed, said method comprising the steps of: a) sampling thepressure in the gas stream of each nare; b) comparing the pressurevariations in the gas stream within each nare; c) comparing theextent of variation of said pressures as between the nares; and d)selecting the nare with the larger pressure variation as the nare that is less obstructed.
- 74. The method of claim 73, wherein the nare that is less obstructedis selected to receive inspired gas.
- 75. The method of claim 73, wherein the nare that is less obstructedis selected for gas sampling.
- 76. The method of claim 73, wherein the nare that is less obstructedis selected for pressure sampling.
- 77. The method of claim 73, wherein the nare that is less obstructedis selected for determination of respiration phase.
- 78. The method of claim 73, wherein the nare that is less obstructed is selected for determination of respiration rate.
- 79. The method of claim 73, wherein the nare that is less obstructedis selected for determination of inhalatory/expiratory time ratio.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/592,943 | 2000-06-13 | ||
US09/592,943 US6938619B1 (en) | 2000-06-13 | 2000-06-13 | Mask free delivery of oxygen and ventilatory monitoring |
PCT/US2001/018891 WO2001095971A2 (en) | 2000-06-13 | 2001-06-13 | Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001268349A1 true AU2001268349A1 (en) | 2002-03-14 |
AU2001268349B2 AU2001268349B2 (en) | 2005-11-17 |
Family
ID=24372686
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268349A Ceased AU2001268349B2 (en) | 2000-06-13 | 2001-06-13 | Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling |
AU6834901A Pending AU6834901A (en) | 2000-06-13 | 2001-06-13 | Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU6834901A Pending AU6834901A (en) | 2000-06-13 | 2001-06-13 | Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling |
Country Status (8)
Country | Link |
---|---|
US (3) | US6938619B1 (en) |
EP (1) | EP1359960A2 (en) |
JP (1) | JP3842212B2 (en) |
CN (1) | CN100361716C (en) |
AU (2) | AU2001268349B2 (en) |
CA (1) | CA2412485C (en) |
MX (1) | MXPA02012452A (en) |
WO (1) | WO2001095971A2 (en) |
Families Citing this family (266)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7640932B2 (en) * | 1997-04-29 | 2010-01-05 | Salter Labs | Nasal cannula for acquiring breathing information |
EP1105096B1 (en) * | 1998-08-19 | 2003-10-29 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
US20050233459A1 (en) * | 2003-11-26 | 2005-10-20 | Melker Richard J | Marker detection method and apparatus to monitor drug compliance |
US20020177232A1 (en) * | 2001-05-23 | 2002-11-28 | Melker Richard J. | Method and apparatus for detecting illicit substances |
NZ518740A (en) | 1999-11-08 | 2004-04-30 | Univ Florida | Marker detection method and apparatus to monitor drug compliance |
US6938619B1 (en) * | 2000-06-13 | 2005-09-06 | Scott Laboratories, Inc. | Mask free delivery of oxygen and ventilatory monitoring |
US6814073B2 (en) | 2000-08-29 | 2004-11-09 | Resmed Limited | Respiratory apparatus with improved flow-flattening detection |
US20070258894A1 (en) * | 2000-11-08 | 2007-11-08 | Melker Richard J | System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring |
US7104963B2 (en) * | 2002-01-22 | 2006-09-12 | University Of Florida Research Foundation, Inc. | Method and apparatus for monitoring intravenous (IV) drug concentration using exhaled breath |
US7462154B2 (en) * | 2001-03-08 | 2008-12-09 | Nihon Kohden Corporation | Sensor for measuring carbon dioxide in respiratory gas |
US7052854B2 (en) * | 2001-05-23 | 2006-05-30 | University Of Florida Research Foundation, Inc. | Application of nanotechnology and sensor technologies for ex-vivo diagnostics |
EP1393069A1 (en) * | 2001-05-24 | 2004-03-03 | The University Of Florida | Method and apparatus for detecting environmental smoke exposure |
US6651656B2 (en) * | 2001-05-29 | 2003-11-25 | Deka Products Limited Partnership | Method and apparatus for non-invasive breathing assist |
DE10296844T5 (en) * | 2001-06-18 | 2004-07-29 | Riggins, Michael A., Seattle | Nasal cannula device for apnea detection |
US8154093B2 (en) | 2002-01-16 | 2012-04-10 | Nanomix, Inc. | Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices |
US8152991B2 (en) | 2005-10-27 | 2012-04-10 | Nanomix, Inc. | Ammonia nanosensors, and environmental control system |
US20070167853A1 (en) * | 2002-01-22 | 2007-07-19 | Melker Richard J | System and method for monitoring health using exhaled breath |
WO2003068301A1 (en) * | 2002-02-15 | 2003-08-21 | Oridion Medical 1987 Ltd. | Dual function nasal cannula |
US7522040B2 (en) * | 2004-04-20 | 2009-04-21 | Nanomix, Inc. | Remotely communicating, battery-powered nanostructure sensor devices |
US7714398B2 (en) * | 2002-09-05 | 2010-05-11 | Nanomix, Inc. | Nanoelectronic measurement system for physiologic gases and improved nanosensor for carbon dioxide |
US20070048181A1 (en) * | 2002-09-05 | 2007-03-01 | Chang Daniel M | Carbon dioxide nanosensor, and respiratory CO2 monitors |
US20070048180A1 (en) * | 2002-09-05 | 2007-03-01 | Gabriel Jean-Christophe P | Nanoelectronic breath analyzer and asthma monitor |
US7034692B2 (en) * | 2002-05-13 | 2006-04-25 | Scott Laboratories, Inc. | System and method for transparent early detection, warning, and intervention during a medical procedure |
MXPA04011423A (en) * | 2002-05-16 | 2005-02-17 | Scott Laborotories Inc | Kits of medical supplies for sedation and analgesia. |
MXPA04011421A (en) * | 2002-05-16 | 2005-02-17 | Scott Lab Inc | User authorization system and method for a sedation and analgesia system. |
US7948041B2 (en) | 2005-05-19 | 2011-05-24 | Nanomix, Inc. | Sensor having a thin-film inhibition layer |
WO2004030723A2 (en) * | 2002-10-03 | 2004-04-15 | Scott Laboratories, Inc. | Bite block apparatus and method for use with a sedation an analgesia system |
US20060160134A1 (en) * | 2002-10-21 | 2006-07-20 | Melker Richard J | Novel application of biosensors for diagnosis and treatment of disease |
WO2004049912A2 (en) * | 2002-12-02 | 2004-06-17 | Scott Laboratories, Inc. | Respiratory monitoring systems and methods |
EP1610681B1 (en) * | 2003-01-23 | 2011-10-05 | University of Florida Research Foundation, Incorporated | Method and apparatus for monitoring intravenous (iv) drug concentration using exhaled breath |
JP4247758B2 (en) * | 2003-02-18 | 2009-04-02 | 日本光電工業株式会社 | Carbon dioxide gas sensor |
EP1599127A4 (en) * | 2003-03-04 | 2009-05-27 | Ethicon Endo Surgery Inc | Patient monitoring and drug delivery system and method of use |
DE10337138A1 (en) * | 2003-08-11 | 2005-03-17 | Freitag, Lutz, Dr. | Method and arrangement for the respiratory assistance of a patient as well as tracheal prosthesis and catheter |
US7588033B2 (en) | 2003-06-18 | 2009-09-15 | Breathe Technologies, Inc. | Methods, systems and devices for improving ventilation in a lung area |
US7066180B2 (en) * | 2003-07-09 | 2006-06-27 | Airmatrix Technologies, Inc. | Method and system for measuring airflow of nares |
WO2005011556A2 (en) * | 2003-07-28 | 2005-02-10 | Salter Labs | Respiratory therapy system including a nasal cannula assembly |
FR2858236B1 (en) | 2003-07-29 | 2006-04-28 | Airox | DEVICE AND METHOD FOR SUPPLYING RESPIRATORY GAS IN PRESSURE OR VOLUME |
AU2003904278A0 (en) | 2003-08-13 | 2003-08-28 | Thomas J. Borody | Improved oral oxygenating device |
AU2004264256B2 (en) * | 2003-08-13 | 2009-09-17 | Thomas J. Borody | Improved oral oxygenating appliance |
US7406966B2 (en) | 2003-08-18 | 2008-08-05 | Menlo Lifesciences, Llc | Method and device for non-invasive ventilation with nasal interface |
WO2005026694A2 (en) * | 2003-09-12 | 2005-03-24 | Nanomix, Inc. | Carbon dioxide nanoelectronic sensor |
US20050066970A1 (en) * | 2003-09-25 | 2005-03-31 | Donofrio William T. | Response testing for conscious sedation using cableless communication |
US20050070824A1 (en) * | 2003-09-29 | 2005-03-31 | Edward Rhad | Response testing for conscious sedation using finger movement response assembly |
US20050070815A1 (en) * | 2003-09-29 | 2005-03-31 | Nasir Shahrestani | Automated audio calibration for conscious sedation |
US7198605B2 (en) * | 2003-09-29 | 2007-04-03 | Ethicon Endo-Surgery, Inc. | Response testing for conscious sedation utilizing a non-ear-canal-contacting speaker |
US20050070814A1 (en) * | 2003-09-29 | 2005-03-31 | Donofrio William T. | Personalized audio requests for conscious sedation |
US7007692B2 (en) * | 2003-10-29 | 2006-03-07 | Airmatrix Technologies, Inc. | Method and system of sensing airflow and delivering therapeutic gas to a patient |
US20050092322A1 (en) * | 2003-11-05 | 2005-05-05 | Collins William L.Jr. | Cannula assembly and medical system employing a known carbon dioxide gas concentration |
EP1694393A1 (en) * | 2003-12-15 | 2006-08-30 | Bespak plc | Nasal drug delivery |
US20050191757A1 (en) * | 2004-01-20 | 2005-09-01 | Melker Richard J. | Method and apparatus for detecting humans and human remains |
US8925545B2 (en) | 2004-02-04 | 2015-01-06 | Breathe Technologies, Inc. | Methods and devices for treating sleep apnea |
US7213594B2 (en) * | 2004-05-20 | 2007-05-08 | Acoba, L.L.C. | Method and system to determine nasal resistance to airflow |
US7007694B2 (en) * | 2004-05-21 | 2006-03-07 | Acoba, Llc | Nasal cannula |
US20060042632A1 (en) * | 2004-08-31 | 2006-03-02 | Bishop Gregory D | Apparatus for monitoring a patient during drug delivery |
US20060062734A1 (en) * | 2004-09-20 | 2006-03-23 | Melker Richard J | Methods and systems for preventing diversion of prescription drugs |
BRPI0518437A2 (en) | 2004-11-16 | 2008-11-18 | Brian Cran | lung treatment device and method |
FR2878751A1 (en) * | 2004-12-03 | 2006-06-09 | Vincent Gerard Henri Dufour | User e.g. aquanaut, monitoring device, for e.g. subaquatic medium, has sensors transmitting parameters of physiology, respiratory apparatus and environment to case with controller storing parameters and display screen displaying parameters |
US20060169281A1 (en) * | 2005-02-03 | 2006-08-03 | Aylsworth Alonzo C | Continuous flow selective delivery of therapeutic gas |
US20060174883A1 (en) * | 2005-02-09 | 2006-08-10 | Acoba, Llc | Method and system of leak detection in application of positive airway pressure |
US20060257883A1 (en) * | 2005-05-10 | 2006-11-16 | Bjoraker David G | Detection and measurement of hematological parameters characterizing cellular blood components |
US9757052B2 (en) * | 2005-05-10 | 2017-09-12 | Oridion Medical (1987) Ltd. | Fluid drying mechanism |
US7644714B2 (en) | 2005-05-27 | 2010-01-12 | Apnex Medical, Inc. | Devices and methods for treating sleep disorders |
US11497407B2 (en) | 2005-09-12 | 2022-11-15 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
US11717174B2 (en) | 2005-09-12 | 2023-08-08 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
US8333199B2 (en) * | 2005-09-12 | 2012-12-18 | Mergenet Medical, Inc. | High flow therapy artificial airway interfaces and related methods |
US11458270B2 (en) | 2005-09-12 | 2022-10-04 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
US11696992B2 (en) | 2005-09-12 | 2023-07-11 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
US11833301B2 (en) | 2005-09-12 | 2023-12-05 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
US7533670B1 (en) | 2005-09-20 | 2009-05-19 | Breathe Technologies, Inc. | Systems, methods and apparatus for respiratory support of a patient |
CN101547716B (en) * | 2005-11-16 | 2013-06-26 | 心肺技术公司 | Side-stream respiratory gas monitoring system and method |
US20080078393A1 (en) * | 2005-11-22 | 2008-04-03 | General Electric Company | Respiratory monitoring with cannula receiving respiratory airflows, differential pressure transducer, and ventilator |
US7422015B2 (en) * | 2005-11-22 | 2008-09-09 | The General Electric Company | Arrangement and method for detecting spontaneous respiratory effort of a patient |
US20070113856A1 (en) * | 2005-11-22 | 2007-05-24 | General Electric Company | Respiratory monitoring with cannula receiving respiratory airflows |
US20070113848A1 (en) * | 2005-11-22 | 2007-05-24 | General Electric Company | Respiratory monitoring with cannula receiving respiratory airflows and exhaled gases |
US20070113847A1 (en) * | 2005-11-22 | 2007-05-24 | General Electric Company | Respiratory monitoring with cannula receiving first respiratory airflows and second respiratory airflows |
US7305988B2 (en) | 2005-12-22 | 2007-12-11 | The General Electric Company | Integrated ventilator nasal trigger and gas monitoring system |
US20070113850A1 (en) * | 2005-11-22 | 2007-05-24 | General Electric Company | Respiratory monitoring with cannula receiving respiratory airflows and differential pressure transducer |
US7578294B2 (en) | 2005-12-02 | 2009-08-25 | Allegiance Corporation | Nasal continuous positive airway pressure device and system |
US7762253B2 (en) | 2005-12-12 | 2010-07-27 | General Electric Company | Multiple lumen monitored drug delivery nasal cannula system |
EP1979030A2 (en) * | 2005-12-14 | 2008-10-15 | Mergenet Medical Inc. | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
AT503096B1 (en) * | 2005-12-16 | 2009-04-15 | Carl Reiner Gmbh | JET ENDOSKOP |
FR2896697B1 (en) * | 2006-02-01 | 2009-04-17 | Air Liquide | DEVICE FOR DELIVERING APPROPRIATE RESPIRATORY OXYGEN QUALITY |
CA2652544A1 (en) * | 2006-05-18 | 2007-12-13 | Breathe Technologies, Inc. | Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer |
WO2007140478A2 (en) * | 2006-05-31 | 2007-12-06 | Masimo Corporation | Respiratory monitoring |
DE102006025263B3 (en) * | 2006-05-31 | 2007-12-06 | DRäGER AEROSPACE GMBH | Sauerstoffnotversorgungsvorrichtung |
EP2051760B1 (en) * | 2006-07-28 | 2014-03-12 | ResMed Limited | Patient interface |
WO2008019102A2 (en) | 2006-08-03 | 2008-02-14 | Breathe Technologies, Inc. | Methods and devices for minimally invasive respiratory support |
RU2447871C2 (en) * | 2006-08-04 | 2012-04-20 | РИК ИНВЕСТМЕНТС ЭлЭлСи. | Nasal and oral patient interface |
US8161971B2 (en) * | 2006-08-04 | 2012-04-24 | Ric Investments, Llc | Nasal and oral patient interface |
US7914460B2 (en) | 2006-08-15 | 2011-03-29 | University Of Florida Research Foundation, Inc. | Condensate glucose analyzer |
US11318267B2 (en) | 2006-09-12 | 2022-05-03 | ResMed Pty Ltd | High flow therapy device utilizing a non-sealing respiratory interface and related methods |
JP5034406B2 (en) * | 2006-09-22 | 2012-09-26 | ヤマハ株式会社 | Electronic wind instrument |
US9913982B2 (en) | 2011-01-28 | 2018-03-13 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US8855771B2 (en) | 2011-01-28 | 2014-10-07 | Cyberonics, Inc. | Screening devices and methods for obstructive sleep apnea therapy |
US9205262B2 (en) | 2011-05-12 | 2015-12-08 | Cyberonics, Inc. | Devices and methods for sleep apnea treatment |
US8417343B2 (en) | 2006-10-13 | 2013-04-09 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9744354B2 (en) | 2008-12-31 | 2017-08-29 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9186511B2 (en) | 2006-10-13 | 2015-11-17 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US20080177152A1 (en) * | 2007-01-24 | 2008-07-24 | Donofrio William T | Response testing for conscious sedation utilizing a non-ear-canal-contacting speaker |
EP1961438A1 (en) * | 2007-02-23 | 2008-08-27 | The General Electric Company | Inhalation anaesthesia delivery system and method |
DE502007002037D1 (en) * | 2007-04-11 | 2009-12-31 | Pari Gmbh | Aerosol therapy device |
US8001968B2 (en) * | 2007-05-09 | 2011-08-23 | Doty Robert H | Apparatus for delivering and/or scavenging gas in the nose/mouth area of a patient |
WO2008144589A1 (en) | 2007-05-18 | 2008-11-27 | Breathe Technologies, Inc. | Methods and devices for sensing respiration and providing ventilation therapy |
KR101397207B1 (en) * | 2007-06-12 | 2014-05-20 | 삼성전자주식회사 | Method and apparatus for receiving/transmitting common control channels in a mobile communication system |
EP2178590B1 (en) * | 2007-07-18 | 2021-04-21 | Vapotherm, Inc. | System for delivering a heated and humidified gas |
US20090065007A1 (en) | 2007-09-06 | 2009-03-12 | Wilkinson William R | Oxygen concentrator apparatus and method |
CA2700878C (en) | 2007-09-26 | 2018-07-24 | Breathe Technologies, Inc. | Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy |
US8905023B2 (en) | 2007-10-05 | 2014-12-09 | Vapotherm, Inc. | Hyperthermic humidification system |
US9205215B2 (en) * | 2007-11-16 | 2015-12-08 | Fisher & Paykel Health Limited | Nasal pillows with high volume bypass flow and method of using same |
US8220458B2 (en) * | 2007-11-29 | 2012-07-17 | Mergenet Medical, Inc. | Artificial airway interfaces and methods thereof |
CN101468236B (en) * | 2007-12-25 | 2012-03-28 | 北京谊安医疗系统股份有限公司 | Certificated valve |
US8683998B2 (en) * | 2008-01-04 | 2014-04-01 | Koninklijke Philips N.V. | Multipurpose cannula |
WO2009092057A1 (en) * | 2008-01-18 | 2009-07-23 | Menlolife, Inc. | Methods and devices for improving efficacy of non-invasive ventilation |
WO2009094532A1 (en) * | 2008-01-25 | 2009-07-30 | Salter Labs | Respiratory therapy system including a nasal cannula assembly |
US8425428B2 (en) | 2008-03-31 | 2013-04-23 | Covidien Lp | Nitric oxide measurements in patients using flowfeedback |
JP5758799B2 (en) | 2008-04-18 | 2015-08-05 | ブリーズ・テクノロジーズ・インコーポレーテッド | Method and device for sensing respiratory effects and controlling ventilator function |
EP2274036A4 (en) | 2008-04-18 | 2014-08-13 | Breathe Technologies Inc | Methods and devices for sensing respiration and controlling ventilator functions |
US8251876B2 (en) | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
JP2011522570A (en) * | 2008-04-29 | 2011-08-04 | オリディオン メディカル 1987 リミテッド | Wireless capnography |
US8457706B2 (en) | 2008-05-16 | 2013-06-04 | Covidien Lp | Estimation of a physiological parameter using a neural network |
US20090283097A1 (en) * | 2008-05-19 | 2009-11-19 | Ethicon Endo-Surgery, Inc. | Medical cannula assembly for use with a patient |
US20090306528A1 (en) * | 2008-06-06 | 2009-12-10 | Salter Labs | Adaptive temperature sensor for breath monitoring device |
US20100168600A1 (en) * | 2008-06-06 | 2010-07-01 | Salter Labs | Support structure for airflow temperature sensor and the method of using the same |
EP2299908A2 (en) | 2008-06-06 | 2011-03-30 | Salter Labs | Adaptive temperature sensor for breath monitoring device |
US20090306529A1 (en) * | 2008-06-06 | 2009-12-10 | Salter Labs | Adaptive temperature sensor for breath monitoring device |
EP2326376B1 (en) | 2008-08-22 | 2019-07-24 | Breathe Technologies, Inc. | Devices for providing mechanical ventilation with an open airway interface |
US8302602B2 (en) | 2008-09-30 | 2012-11-06 | Nellcor Puritan Bennett Llc | Breathing assistance system with multiple pressure sensors |
US8652064B2 (en) | 2008-09-30 | 2014-02-18 | Covidien Lp | Sampling circuit for measuring analytes |
JP5711661B2 (en) | 2008-10-01 | 2015-05-07 | ブリーズ・テクノロジーズ・インコーポレーテッド | Ventilator with biofeedback monitoring and controls to improve patient activity and health |
US9044565B2 (en) * | 2008-10-30 | 2015-06-02 | Oridion Medical (1987) Ltd. | Oral-nasal cannula system enabling CO2 and breath flow measurement |
US8082312B2 (en) | 2008-12-12 | 2011-12-20 | Event Medical, Inc. | System and method for communicating over a network with a medical device |
US9055888B2 (en) * | 2009-01-05 | 2015-06-16 | Oridion Medical (1987) Ltd. | Exhaled breath sampling with delivery of gas |
US9132250B2 (en) | 2009-09-03 | 2015-09-15 | Breathe Technologies, Inc. | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature |
US8453649B2 (en) * | 2009-02-18 | 2013-06-04 | 0200L, Llc | Apparatus for positioning a nasal cannula |
US8434479B2 (en) | 2009-02-27 | 2013-05-07 | Covidien Lp | Flow rate compensation for transient thermal response of hot-wire anemometers |
JP5575223B2 (en) | 2009-04-02 | 2014-08-20 | ブリーズ・テクノロジーズ・インコーポレーテッド | Non-invasive ventilation systems, systems that reduce patient airway obstruction, and devices that treat sleep apnea |
US9962512B2 (en) | 2009-04-02 | 2018-05-08 | Breathe Technologies, Inc. | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature |
EP2445409A1 (en) * | 2009-06-25 | 2012-05-02 | Clearway Medical Limited | A respiratory monitoring system |
US9364623B2 (en) | 2009-07-15 | 2016-06-14 | UNIVERSITé LAVAL | Method and device for administering oxygen to a patient and monitoring the patient |
JP2013501921A (en) | 2009-08-07 | 2013-01-17 | ナノミックス・インコーポレーテッド | Biological detection based on magnetic carbon nanotubes |
EP2283773A1 (en) * | 2009-08-10 | 2011-02-16 | Koninklijke Philips Electronics N.V. | Processing a breathing signal |
SG10201502886VA (en) | 2009-08-13 | 2015-05-28 | Hidetsugu Asanoi | Device For Calculating Respiratory Waveform Information And Medical Device Using Respiratory Waveform Information |
CN102625720B (en) * | 2009-09-03 | 2019-04-12 | 呼吸科技公司 | For including the mthods, systems and devices with the invasive ventilation of non-tight vented interface of free space nozzle characteristics |
CA2774902C (en) | 2009-09-03 | 2017-01-03 | Breathe Technologies, Inc. | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature |
EP2473220B1 (en) * | 2009-09-03 | 2018-11-07 | Breathe Technologies, Inc. | System for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature |
RU2580188C2 (en) * | 2009-11-03 | 2016-04-10 | Конинклейке Филипс Электроникс Н.В. | System and method for breath control |
US8439036B2 (en) | 2009-12-01 | 2013-05-14 | Covidien Lp | Exhalation valve assembly with integral flow sensor |
US8439037B2 (en) | 2009-12-01 | 2013-05-14 | Covidien Lp | Exhalation valve assembly with integrated filter and flow sensor |
US8469031B2 (en) | 2009-12-01 | 2013-06-25 | Covidien Lp | Exhalation valve assembly with integrated filter |
US8469030B2 (en) | 2009-12-01 | 2013-06-25 | Covidien Lp | Exhalation valve assembly with selectable contagious/non-contagious latch |
WO2011080701A1 (en) | 2009-12-29 | 2011-07-07 | Koninklijke Philips Electronics N.V. | System and method for detecting valid breaths from a capnometry signal |
CA2786747C (en) | 2010-01-13 | 2017-05-16 | Thomas Julius Borody | A mask for use with a patient undergoing a sedated endoscopic procedure |
US8171094B2 (en) * | 2010-01-19 | 2012-05-01 | Event Medical, Inc. | System and method for communicating over a network with a medical device |
USD655405S1 (en) | 2010-04-27 | 2012-03-06 | Nellcor Puritan Bennett Llc | Filter and valve body for an exhalation module |
USD653749S1 (en) | 2010-04-27 | 2012-02-07 | Nellcor Puritan Bennett Llc | Exhalation module filter body |
USD655809S1 (en) | 2010-04-27 | 2012-03-13 | Nellcor Puritan Bennett Llc | Valve body with integral flow meter for an exhalation module |
US8905019B2 (en) * | 2010-05-11 | 2014-12-09 | Carefusion 207, Inc. | Patient circuit integrity alarm using exhaled CO2 |
US8695591B2 (en) | 2010-05-26 | 2014-04-15 | Lloyd Verner Olson | Apparatus and method of monitoring and responding to respiratory depression |
WO2012024342A1 (en) | 2010-08-16 | 2012-02-23 | Breathe Technologies, Inc. | Methods, systems and devices using lox to provide ventilatory support |
US8616207B2 (en) | 2010-09-07 | 2013-12-31 | Inova Labs, Inc. | Oxygen concentrator heat management system and method |
US8603228B2 (en) | 2010-09-07 | 2013-12-10 | Inova Labs, Inc. | Power management systems and methods for use in an oxygen concentrator |
US8786698B2 (en) * | 2010-09-23 | 2014-07-22 | Sony Computer Entertainment Inc. | Blow tracking user interface system and method |
US8638364B2 (en) | 2010-09-23 | 2014-01-28 | Sony Computer Entertainment Inc. | User interface system and method using thermal imaging |
BR112013006931A2 (en) | 2010-09-30 | 2016-07-12 | Breathe Technologies Inc | methods, systems and devices for respiratory tract humidification |
US8567400B2 (en) | 2010-10-05 | 2013-10-29 | Carefusion 207, Inc. | Non-invasive breathing assistance device with flow director |
US8607794B2 (en) | 2010-10-05 | 2013-12-17 | Carefusion 207, Inc. | Non-invasive breathing assistance apparatus and method |
CN107773824B (en) * | 2010-10-18 | 2023-12-29 | 费雪派克医疗保健有限公司 | Nasal cannula, catheter and fixation system |
DE102010054397A1 (en) * | 2010-12-08 | 2012-06-14 | Aerocrine Ab | Method and apparatus for gas sampling |
JP2014505532A (en) | 2010-12-31 | 2014-03-06 | オーツーオーオーエル,エルエルシー | Nasal cannula positioning device |
WO2012095813A1 (en) * | 2011-01-13 | 2012-07-19 | UNIVERSITé LAVAL | Method and system for the delivery of carbon dioxide to a patient |
WO2012128704A1 (en) | 2011-03-24 | 2012-09-27 | Fraanberg Oskar | A device and method for supplying and dosing gas to a breathing person |
US9629971B2 (en) | 2011-04-29 | 2017-04-25 | Covidien Lp | Methods and systems for exhalation control and trajectory optimization |
US9092559B2 (en) | 2011-08-16 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Drug delivery system with open architectural framework |
US9138169B2 (en) | 2011-09-07 | 2015-09-22 | Monitor Mask Inc. | Oxygen facemask with capnography monitoring ports |
MX2014003317A (en) * | 2011-09-22 | 2014-04-25 | Koninkl Philips Nv | Supplemental gas delivery and monitoring system. |
US20130092165A1 (en) * | 2011-09-26 | 2013-04-18 | Anthony David Wondka | Nasal Ventilation Cannula System and Methods |
EP2747818B1 (en) * | 2011-10-19 | 2016-09-14 | Koninklijke Philips N.V. | Detecting mouth-breathing in early phase expiration |
US9089657B2 (en) | 2011-10-31 | 2015-07-28 | Covidien Lp | Methods and systems for gating user initiated increases in oxygen concentration during ventilation |
US9364624B2 (en) | 2011-12-07 | 2016-06-14 | Covidien Lp | Methods and systems for adaptive base flow |
US9498589B2 (en) | 2011-12-31 | 2016-11-22 | Covidien Lp | Methods and systems for adaptive base flow and leak compensation |
WO2013118098A1 (en) * | 2012-02-09 | 2013-08-15 | Koninklijke Philips N.V. | Gas sampling device and method |
US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
US8844526B2 (en) | 2012-03-30 | 2014-09-30 | Covidien Lp | Methods and systems for triggering with unknown base flow |
US9144658B2 (en) | 2012-04-30 | 2015-09-29 | Covidien Lp | Minimizing imposed expiratory resistance of mechanical ventilator by optimizing exhalation valve control |
FR2992223B1 (en) | 2012-06-21 | 2015-05-01 | Deltamedics | OROPHARY NERVE CANNULA COMPRISING A DIOXYGEN ARRIVAL AND A CARBON DIOXIDE EXTRACTION |
EP2906278B1 (en) | 2012-10-12 | 2019-01-30 | Inova Labs, Inc. | Systems for the delivery of oxygen enriched gas |
NZ707159A (en) | 2012-10-12 | 2018-06-29 | Inova Labs Inc | Dual oxygen concentrator systems and methods |
NZ707260A (en) | 2012-10-12 | 2017-12-22 | Inova Labs Inc | Oxygen concentrator systems and methods |
US9375542B2 (en) | 2012-11-08 | 2016-06-28 | Covidien Lp | Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation |
SI2928531T1 (en) | 2012-12-04 | 2017-07-31 | Ino Therapeutics LLC Perryville III Corporate Park | Cannula for minimizing dilution of dosing during nitric oxide delivery |
US9795756B2 (en) | 2012-12-04 | 2017-10-24 | Mallinckrodt Hospital Products IP Limited | Cannula for minimizing dilution of dosing during nitric oxide delivery |
JP6424172B2 (en) * | 2013-01-08 | 2018-11-14 | キャプニア, インク.Capnia, Inc. | Breathing selection for analysis |
EP2953538B1 (en) | 2013-02-11 | 2018-10-17 | Monitor Mask Inc. | Oxygen face mask and component system |
USD731049S1 (en) | 2013-03-05 | 2015-06-02 | Covidien Lp | EVQ housing of an exhalation module |
USD736905S1 (en) | 2013-03-08 | 2015-08-18 | Covidien Lp | Exhalation module EVQ housing |
USD701601S1 (en) | 2013-03-08 | 2014-03-25 | Covidien Lp | Condensate vial of an exhalation module |
USD731048S1 (en) | 2013-03-08 | 2015-06-02 | Covidien Lp | EVQ diaphragm of an exhalation module |
USD692556S1 (en) | 2013-03-08 | 2013-10-29 | Covidien Lp | Expiratory filter body of an exhalation module |
USD731065S1 (en) | 2013-03-08 | 2015-06-02 | Covidien Lp | EVQ pressure sensor filter of an exhalation module |
USD744095S1 (en) | 2013-03-08 | 2015-11-24 | Covidien Lp | Exhalation module EVQ internal flow sensor |
USD693001S1 (en) | 2013-03-08 | 2013-11-05 | Covidien Lp | Neonate expiratory filter assembly of an exhalation module |
US9981096B2 (en) | 2013-03-13 | 2018-05-29 | Covidien Lp | Methods and systems for triggering with unknown inspiratory flow |
FR3003176B1 (en) | 2013-03-15 | 2015-03-13 | Deltamedics | NASOPHARYNGEE CANNULA FOR SECONDARY FLOW CAPNOGRAPHY |
US9950135B2 (en) | 2013-03-15 | 2018-04-24 | Covidien Lp | Maintaining an exhalation valve sensor assembly |
EP4275731A3 (en) | 2013-03-15 | 2023-12-27 | Fisher & Paykel Healthcare Limited | Nasal cannula assemblies |
DE102013206111A1 (en) | 2013-04-08 | 2014-10-09 | Robert Bosch Gmbh | Device for combined respiratory gas analysis and pulmonary function testing |
US9486600B2 (en) * | 2013-06-28 | 2016-11-08 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with inhalation valves communicating with a deformable reservoir |
US9522248B2 (en) * | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage |
US9566407B2 (en) * | 2013-06-28 | 2017-02-14 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with flow control passage communicating with a deformable reservoir |
US9522247B2 (en) * | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of treating a patient having pulmonary hypertension by long term NO therapy |
US9492626B2 (en) * | 2013-06-28 | 2016-11-15 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance assemblies suitable for long term no therapy |
US9517318B2 (en) * | 2013-06-28 | 2016-12-13 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir |
ES2914031T3 (en) | 2013-08-09 | 2022-06-07 | Fisher & Paykel Healthcare Ltd | Asymmetric nasal delivery elements and accessories for nasal interfaces |
DE202013103647U1 (en) | 2013-08-12 | 2013-09-02 | Aspect Imaging Ltd. | A system for online measurement and control of O2 fraction, CO fraction and CO2 fraction |
USD753816S1 (en) | 2013-12-12 | 2016-04-12 | Monitor Mask Inc. | Oxygen face mask with capnography monitoring ports |
US11383083B2 (en) | 2014-02-11 | 2022-07-12 | Livanova Usa, Inc. | Systems and methods of detecting and treating obstructive sleep apnea |
US9440179B2 (en) | 2014-02-14 | 2016-09-13 | InovaLabs, LLC | Oxygen concentrator pump systems and methods |
WO2015156690A1 (en) * | 2014-04-11 | 2015-10-15 | Fisher & Paykel Heathcare Limited | Gas therapy system |
US11413416B2 (en) | 2014-07-23 | 2022-08-16 | Diana B. Thomas | Endopharyngeal airway positive pressure ventilation device |
US9808591B2 (en) | 2014-08-15 | 2017-11-07 | Covidien Lp | Methods and systems for breath delivery synchronization |
US20200188617A1 (en) * | 2014-10-03 | 2020-06-18 | Auckland University Of Technology | Method and apparatus for the controlled delivery of gases |
US9950129B2 (en) | 2014-10-27 | 2018-04-24 | Covidien Lp | Ventilation triggering using change-point detection |
US10143820B2 (en) | 2014-12-12 | 2018-12-04 | Dynasthetics, Llc | System and method for delivery of variable oxygen flow |
US10159815B2 (en) | 2014-12-12 | 2018-12-25 | Dynasthetics, Llc | System and method for detection of oxygen delivery failure |
WO2016108127A1 (en) * | 2014-12-30 | 2016-07-07 | Koninklijke Philips N.V. | Capnometry system with supplemental oxygen detection and method of operation thereof |
US10596345B2 (en) | 2014-12-31 | 2020-03-24 | Vapotherm, Inc. | Systems and methods for humidity control |
US9925346B2 (en) | 2015-01-20 | 2018-03-27 | Covidien Lp | Systems and methods for ventilation with unknown exhalation flow |
FR3033704A1 (en) | 2015-03-20 | 2016-09-23 | Deltamedics | IMPROVED ORO- OR NASO-PHARYNGEAL CANNULA |
SG10201909092SA (en) * | 2015-03-31 | 2019-11-28 | Fisher & Paykel Healthcare Ltd | A user interface and system for supplying gases to an airway |
US10398871B2 (en) | 2015-03-31 | 2019-09-03 | Vapotherm, Inc. | Systems and methods for patient-proximate vapor transfer for respiratory therapy |
CN111603643B (en) | 2015-04-02 | 2023-05-23 | 希尔-罗姆服务私人有限公司 | Pressure control of breathing apparatus |
USD775345S1 (en) | 2015-04-10 | 2016-12-27 | Covidien Lp | Ventilator console |
JP6847055B2 (en) | 2015-06-11 | 2021-03-24 | レボリューショナリー メディカル デバイシーズ,インコーポレイテッド | Ventilation mask |
CN106823091B (en) * | 2015-07-22 | 2019-03-05 | 王永超 | A kind of internal medicine oxygen face mask |
JP7082064B2 (en) * | 2016-04-29 | 2022-06-07 | フィッシャー アンド ペイケル ヘルスケア リミテッド | System for determining airway patency |
US11458274B2 (en) | 2016-05-03 | 2022-10-04 | Inova Labs, Inc. | Method and systems for the delivery of oxygen enriched gas |
CN105944212A (en) * | 2016-05-18 | 2016-09-21 | 湖南明康中锦医疗科技发展有限公司 | Noise-reducing mask of respirator and respirator provided with noise-reducing mask |
CN106037745A (en) * | 2016-07-08 | 2016-10-26 | 宋颖霞 | Respiration detecting device for medical nursing and diagnosis |
WO2018048883A1 (en) | 2016-09-06 | 2018-03-15 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Anesthesia gas delivery and monitoring system |
EP3512422B1 (en) * | 2016-09-14 | 2021-12-29 | Revolutionary Medical Devices, Inc. | Ventilation mask |
USD870269S1 (en) | 2016-09-14 | 2019-12-17 | Fisher & Paykel Healthcare Limited | Nasal cannula assembly |
AU2017341838A1 (en) | 2016-10-14 | 2019-05-02 | Vapotherm, Inc. | Systems and methods for high velocity nasal insufflation |
CN106860988B (en) * | 2017-03-09 | 2023-05-26 | 南昌大学第二附属医院 | Intelligent regulation and control artificial nose safety airbag control system |
CN108685575B (en) * | 2017-04-10 | 2023-06-02 | 中国人民解放军总医院 | Respiratory system function test method and device |
CN107096104A (en) * | 2017-06-08 | 2017-08-29 | 湖南明康中锦医疗科技发展有限公司 | A kind of Oxygen therapy apparatus and its nasal tube road |
SE542712C2 (en) * | 2017-08-10 | 2020-06-30 | Dr No Invest As | Medical tube fixation arrangement |
WO2019038112A1 (en) * | 2017-08-22 | 2019-02-28 | Koninklijke Philips N.V. | Breathing mask and mask control method |
US10792449B2 (en) | 2017-10-03 | 2020-10-06 | Breathe Technologies, Inc. | Patient interface with integrated jet pump |
CN111801048A (en) * | 2018-02-20 | 2020-10-20 | 明尼苏达大学董事会 | Breath sampling mask and system |
US11859750B2 (en) | 2018-03-16 | 2024-01-02 | Dirtt Environmental Solutions Ltd. | Med-gas panel connectors for reconfigurable walls |
CN108744213A (en) * | 2018-03-31 | 2018-11-06 | 湖南明康中锦医疗科技发展有限公司 | Breathing mask and its application |
USD885556S1 (en) | 2018-04-13 | 2020-05-26 | Fisher & Paykel Healthcare Limited | Tip, tube and clip assembly for a gas sampling apparatus |
JP2021524795A (en) * | 2018-05-13 | 2021-09-16 | サミール・サレハ・アフマド | Portable medical ventilator system using a portable oxygen concentrator |
CN108888233A (en) * | 2018-08-17 | 2018-11-27 | 广州维力医疗器械股份有限公司 | It is a kind of monitoring end-expiratory carbon dioxide and can oxygen supply oral scope be difficult to articulate |
CN109276788A (en) * | 2018-08-24 | 2019-01-29 | 广州康智件科技有限公司 | A kind of respiratory rate acquisition method and its device for oxygen uptake monitoring |
CN110327525B (en) * | 2019-05-27 | 2021-06-08 | 西昌市人民医院 | Nasal obstruction catheter fixing device matched with CPAP (continuous positive airway pressure) breathing machine for neonates |
US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
CN110665134B (en) * | 2019-09-02 | 2021-01-12 | 余继跃 | Ear-wearing waist-hanging body-building aerator |
CN111330130A (en) * | 2020-03-04 | 2020-06-26 | 深圳市量子氢生物技术有限公司 | Cavity-divided type nasal suction tube |
US11896767B2 (en) | 2020-03-20 | 2024-02-13 | Covidien Lp | Model-driven system integration in medical ventilators |
US11878120B2 (en) * | 2020-08-11 | 2024-01-23 | 3B Medical, Inc. | Control system for portable oxygen concentrator |
DE102020121871A1 (en) * | 2020-08-20 | 2022-02-24 | Drägerwerk AG & Co. KGaA | High flow oxygen therapy ventilator |
WO2022183099A1 (en) * | 2021-02-26 | 2022-09-01 | Pneuma Therapeutics, Inc. | Oral end tidal collection apparatus and method |
CN113018627A (en) * | 2021-03-08 | 2021-06-25 | 南昌大学第一附属医院 | Nasal oxygen inhalation catheter connector capable of being connected with anesthesia machine |
CN113606763A (en) * | 2021-07-09 | 2021-11-05 | 武汉天富海科技发展有限公司 | Intelligent dispersed oxygen supply control terminal |
CN114403851B (en) * | 2022-03-09 | 2023-09-08 | 山东省千佛山医院 | Converter for monitoring end-tidal carbon dioxide and application method thereof |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4151843A (en) | 1976-06-28 | 1979-05-01 | Brekke John H | Apparatus for administration of a gas to a human and the exhausting thereof |
SE402569B (en) | 1976-11-09 | 1978-07-10 | Aga Ab | DEVICE FOR A DIVERSE DEVICE FOR DIVERS |
US4263908A (en) * | 1979-07-25 | 1981-04-28 | Mizerak Vladimir S | Nasal cannula mask |
US4550726A (en) | 1982-07-15 | 1985-11-05 | Mcewen James A | Method and apparatus for detection of breathing gas interruptions |
US4602644A (en) * | 1982-08-18 | 1986-07-29 | Plasmedics, Inc. | Physiological detector and monitor |
US4618099A (en) | 1984-07-13 | 1986-10-21 | Kyushu Hitachi Maxell, Ltd. | Electric spray |
US4612928A (en) | 1984-08-28 | 1986-09-23 | Tiep Brian L | Method and apparatus for supplying a gas to a body |
US4686975A (en) | 1985-05-03 | 1987-08-18 | Applied Membrane Technology, Inc. | Electronic respirable gas delivery device |
JPS6294175A (en) | 1985-10-18 | 1987-04-30 | 鳥取大学長 | Respiration synchronous type gas blowing apparatus and method |
JPH0622135Y2 (en) | 1986-01-13 | 1994-06-08 | 石川ガスケット株式会社 | Metal stack type manifold gasket |
US5050614A (en) | 1986-08-06 | 1991-09-24 | Spacelabs, Inc. | Apparatus and method for inspiration detection |
US5099836A (en) | 1987-10-05 | 1992-03-31 | Hudson Respiratory Care Inc. | Intermittent oxygen delivery system and cannula |
US4924876A (en) | 1987-11-04 | 1990-05-15 | Peter Cameron | Nasal breath monitor |
US5003985A (en) | 1987-12-18 | 1991-04-02 | Nippon Colin Co., Ltd. | End tidal respiratory monitor |
US4858476A (en) * | 1988-01-25 | 1989-08-22 | The United States Of America As Represented By The United States Department Of Energy | Breathing zone air sampler |
US5074299A (en) | 1988-05-02 | 1991-12-24 | Dietz Henry G | Monitor for controlling the flow of gases for breathing during inhalation |
FI82803C (en) | 1988-09-02 | 1991-04-25 | Instrumentarium Oy | A method for determining the content of a gas component in a patient's breathing air |
GB8824865D0 (en) | 1988-10-24 | 1988-11-30 | Antec Systems | Gas sampling device & water trap |
US5005571A (en) * | 1988-11-25 | 1991-04-09 | Dietz Henry G | Mouth nose mask for use with an inhalation therapy and/or breathing monitoring apparatus |
US5632269A (en) * | 1989-09-22 | 1997-05-27 | Respironics Inc. | Breathing gas delivery method and apparatus |
US5046491A (en) | 1990-03-27 | 1991-09-10 | Derrick Steven J | Apparatus and method for respired gas collection and analysis |
US5402796A (en) * | 1990-09-19 | 1995-04-04 | University Of Melbourne | Arterial CO2 Monitor and closed loop controller |
US5365922A (en) | 1991-03-19 | 1994-11-22 | Brigham And Women's Hospital, Inc. | Closed-loop non-invasive oxygen saturation control system |
DE4111965C2 (en) | 1991-04-12 | 2000-03-23 | Draegerwerk Ag | Method for calibrating a flow sensor in a breathing system |
US5099834A (en) * | 1991-07-16 | 1992-03-31 | Union Carbide Industrial Gases Technology Corporation | Method for anesthesia |
US5490502A (en) * | 1992-05-07 | 1996-02-13 | New York University | Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea |
CA2096302A1 (en) | 1992-05-15 | 1993-11-16 | David Kilis | Air flow controller and recording system |
US5400781A (en) * | 1993-08-03 | 1995-03-28 | Davenport; Richard A. | CO2 gas sampling mask having a bevelled sampling tube extending into the mask |
US5485850A (en) | 1993-08-13 | 1996-01-23 | Dietz; Henry G. | Monitor of low pressure intervals with control capabilities |
US5474060A (en) | 1993-08-23 | 1995-12-12 | Evans; David | Face mask with gas sampling port |
US5433195A (en) * | 1993-09-30 | 1995-07-18 | Sherwood Medical Company | Respiratory support system |
US5386833A (en) | 1993-12-23 | 1995-02-07 | Biochem International, Inc. | Method for calibrating a carbon dioxide monitor |
US5509414A (en) * | 1994-09-27 | 1996-04-23 | Hok Instrument Ab | Apparatus and method for non-contacting detection of respiration |
FI96579C (en) * | 1994-11-14 | 1996-07-25 | Instrumentarium Oy | Method to prevent the formation of dangerous vacuum in the respiratory system |
US5800361A (en) | 1995-02-06 | 1998-09-01 | Ntc Technology Inc. | Non-invasive estimation of arterial blood gases |
US5735268A (en) * | 1995-06-07 | 1998-04-07 | Salter Labs | Intermitten gas-insufflation apparatus and method therefor |
US5626131A (en) * | 1995-06-07 | 1997-05-06 | Salter Labs | Method for intermittent gas-insufflation |
AUPN344195A0 (en) * | 1995-06-08 | 1995-07-06 | Rescare Limited | Monitoring of oro-nasal respiration |
AUPN474195A0 (en) | 1995-08-09 | 1995-08-31 | Rescare Limited | Apparatus and methods for oro-nasal respiration monitoring |
US5694923A (en) * | 1996-08-30 | 1997-12-09 | Respironics, Inc. | Pressure control in a blower-based ventilator |
US5865174A (en) | 1996-10-29 | 1999-02-02 | The Scott Fetzer Company | Supplemental oxygen delivery apparatus and method |
US6439234B1 (en) * | 1998-04-03 | 2002-08-27 | Salter Labs | Nasal cannula |
EP0998318B1 (en) | 1997-07-25 | 2005-04-27 | Minnesota Innovative Technologies & Instruments Corporation (MITI) | Control device for supplying supplemental respiratory oxygen |
US6371114B1 (en) * | 1998-07-24 | 2002-04-16 | Minnesota Innovative Technologies & Instruments Corporation | Control device for supplying supplemental respiratory oxygen |
US6532958B1 (en) * | 1997-07-25 | 2003-03-18 | Minnesota Innovative Technologies & Instruments Corporation | Automated control and conservation of supplemental respiratory oxygen |
SE9703290D0 (en) * | 1997-09-11 | 1997-09-11 | Siemens Elema Ab | ventilator |
SE9703291L (en) | 1997-09-11 | 1998-10-05 | Siemens Elema Ab | inspiration Hose |
US5937858A (en) * | 1997-12-05 | 1999-08-17 | Connell; Donald G. | Oro/nasopharyngeal airway for administering/sampling inhalent/expired gases |
IL123122A0 (en) * | 1998-01-29 | 1998-09-24 | Oridion Medical Ltd | Oral/nasal cannula |
US6017315A (en) | 1998-02-25 | 2000-01-25 | Respironics, Inc. | Patient monitor and method of using same |
JP4080591B2 (en) | 1998-04-24 | 2008-04-23 | 株式会社群馬コイケ | Respiratory oxygen supply device |
US6192884B1 (en) | 1998-05-22 | 2001-02-27 | Duke University | Method and apparatus for supplemental oxygen delivery |
US6213955B1 (en) * | 1998-10-08 | 2001-04-10 | Sleep Solutions, Inc. | Apparatus and method for breath monitoring |
US6467477B1 (en) * | 1999-03-26 | 2002-10-22 | Respironics, Inc. | Breath-based control of a therapeutic treatment |
US6401713B1 (en) * | 1999-05-05 | 2002-06-11 | Respironics, Inc. | Apparatus and method of providing continuous positive airway pressure |
US6247470B1 (en) * | 1999-07-07 | 2001-06-19 | Armen G. Ketchedjian | Oxygen delivery, oxygen detection, carbon dioxide monitoring (ODODAC) apparatus and method |
US6379312B2 (en) * | 1999-12-28 | 2002-04-30 | O'toole James | End tidal carbon dioxide sampling device |
US6938619B1 (en) * | 2000-06-13 | 2005-09-06 | Scott Laboratories, Inc. | Mask free delivery of oxygen and ventilatory monitoring |
-
2000
- 2000-06-13 US US09/592,943 patent/US6938619B1/en not_active Expired - Lifetime
-
2001
- 2001-06-13 AU AU2001268349A patent/AU2001268349B2/en not_active Ceased
- 2001-06-13 JP JP2002510145A patent/JP3842212B2/en not_active Expired - Fee Related
- 2001-06-13 AU AU6834901A patent/AU6834901A/en active Pending
- 2001-06-13 WO PCT/US2001/018891 patent/WO2001095971A2/en active IP Right Grant
- 2001-06-13 CN CNB01813100XA patent/CN100361716C/en not_active Expired - Fee Related
- 2001-06-13 US US09/878,922 patent/US7152604B2/en not_active Expired - Fee Related
- 2001-06-13 EP EP01946277A patent/EP1359960A2/en not_active Withdrawn
- 2001-06-13 MX MXPA02012452A patent/MXPA02012452A/en active IP Right Grant
- 2001-06-13 CA CA002412485A patent/CA2412485C/en not_active Expired - Fee Related
-
2006
- 2006-12-19 US US11/640,930 patent/US7997271B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2412485C (en) | Method and apparatus for mask free delivery of an inspired gas mixture and gas sampling | |
AU2001268349A1 (en) | Apparatus and method for mask free delivery of an inspired gas mixture and gas sampling | |
US20230256185A1 (en) | Oxygen masks | |
US11679218B2 (en) | Oxygen masks | |
US10105099B2 (en) | Nasal and oral patient interfaces | |
JP5318752B2 (en) | Method and apparatus for controlling respiration | |
CA2609856C (en) | Apparatus and method for controlling fraction of inspired oxygen | |
US20070144518A1 (en) | Integrated ventilator nasal trigger and gas monitoring system | |
EP0364567B1 (en) | Method and apparatus for inhalation of treating gas and sampling of exhaled gas for quantitative analysis | |
US20030127094A1 (en) | Apparatus for delivering inhalant and monitoring exhaled fluid, method of making same, and method of delivering inhalant and monitoring exhaled fluid | |
US20030075178A1 (en) | Continuous gas leakage for elimination of ventilator dead space | |
AU2002348458A1 (en) | Continuous gas leakage for elimination of ventilator dead space |